Treffer 1 - 7 von 7 für Suche 'HARRISON, Shuree', Suchdauer: 0,46s Treffer weiter einschränken
  1. 1
    Patient Recruitment 2.0: Become a Partner in the Patient Journey Using Digital Media

    Patient Recruitment 2.0: Become a Partner in the Patient Journey Using Digital Media von Lindemann, Michael, Freeman, Tobe, Kilchenmann, Timothy, Harrison, Shuree, Chan, Margaret, Wygonik, Mark, Haines, Lea, Gossens, Christian

    Veröffentlicht in JMIR research protocols

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    P4-383: Tarenflurbil (MPC-7869), a selective Aβ42-lowering agent, has no significant effect on the pharmacokinetics and pharmacodynamics of warfarin

    P4-383: Tarenflurbil (MPC-7869), a selective Aβ42-lowering agent, has no significant effect on the pharmacokinetics and pharmacodynamics of warfarin von Mather, Gary, Harrison, Shuree, Woodland, Deane, Swabb, Edward

    Veröffentlicht in Alzheimer's & dementia

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    P4-362: Tarenflurbil clearance is not reduced in subjects with mild or moderate hepatic impairment

    P4-362: Tarenflurbil clearance is not reduced in subjects with mild or moderate hepatic impairment von Dowd, Brian, Harrison, Shuree, Woodland, Deane, Swabb, Edward, Mather, Gary

    Veröffentlicht in Alzheimer's & dementia

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    P4-395: Inhibition of CYP2C9 by fluconazole reduces clearance and increases exposure to tarenflurbil

    P4-395: Inhibition of CYP2C9 by fluconazole reduces clearance and increases exposure to tarenflurbil von Swabb, Edward, Harrison, Shuree, Woodland, Deane, Belcher, Valerie, Mather, Gary

    Veröffentlicht in Alzheimer's & dementia

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  5. 5
    Design, synthesis and biological activity of novel dimethyl-{2-[6-substituted-indol-1-yl]-ethyl}-amine as potent, selective, and orally-bioavailable 5-HT1D agonists

    Design, synthesis and biological activity of novel dimethyl-{2-[6-substituted-indol-1-yl]-ethyl}-amine as potent, selective, and orally-bioavailable 5-HT1D agonists von ISAAC, Methvin, SLASSI, Malik, NAISMITH, Angela, MADDAFORD, Shawn, PAPAC, Damon, HARRISON, Shuree, HUA WANG, DRANER, Stan, TEHIM, Ashok, TAO XIN, ARORA, Jalaj, O'BRIEN, Anne, EDWARDS, Louise, MACLEAN, Neil, WILSON, Julie, DEMSCHYSHYN, Lidia, LABRIE, Phillipe


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  6. 6
    Design, synthesis and biological activity of novel dimethyl-[2-[6-substituted-indol-1-yl]-ethyl]-amine as potent, selective, and orally-bioavailable 5-HT(1D) agonists

    Design, synthesis and biological activity of novel dimethyl-[2-[6-substituted-indol-1-yl]-ethyl]-amine as potent, selective, and orally-bioavailable 5-HT(1D) agonists von Isaac, Methvin, Slassi, Malik, Xin, Tao, Arora, Jalaj, O'Brien, Anne, Edwards, Louise, MacLean, Neil, Wilson, Julie, Demschyshyn, Lidia, Labrie, Phillipe, Naismith, Angela, Maddaford, Shawn, Papac, Damon, Harrison, Shuree, Wang, Hua, Draper, Stan, Tehim, Ashok


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  7. 7
    Design, synthesis and biological activity of novel dimethyl-{2-[6-substituted-indol-1-yl]-ethyl}-amine as potent, selective, and orally-Bioavailable 5-HT 1D agonists

    Design, synthesis and biological activity of novel dimethyl-{2-[6-substituted-indol-1-yl]-ethyl}-amine as potent, selective, and orally-Bioavailable 5-HT 1D agonists von Isaac, Methvin, Slassi, Malik, Xin, Tao, Arora, Jalaj, O'Brien, Anne, Edwards, Louise, MacLean, Neil, Wilson, Julie, Demschyshyn, Lidia, Labrie, Phillipe, Naismith, Angela, Maddaford, Shawn, Papac, Damon, Harrison, Shuree, Wang, Hua, Draper, Stan, Tehim, Ashok


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: